Page last updated: 2024-08-24

glucuronic acid and sb 202190

glucuronic acid has been researched along with sb 202190 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aboka, AM; Georgescu, H; Gilbertson, LG; Kang, JD; Sowa, G; Studer, RK; Vo, N	1

Other Studies

1 other study(ies) available for glucuronic acid and sb 202190

Article	Year
p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration. Spine, 2007, Dec-01, Volume: 32, Issue:25 Topics: Adult; Alginates; Cell Culture Techniques; Cells, Cultured; Culture Media, Conditioned; Dinoprostone; Female; Glucuronic Acid; Hexuronic Acids; Humans; Imidazoles; Interleukin-1beta; Intervertebral Disc; Male; Matrix Metalloproteinase 3; Middle Aged; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Signal Transduction; Spinal Diseases; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha	2007

Article

Year

p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration.

Spine, 2007, Dec-01, Volume: 32, Issue:25

Topics: Adult; Alginates; Cell Culture Techniques; Cells, Cultured; Culture Media, Conditioned; Dinoprostone; Female; Glucuronic Acid; Hexuronic Acids; Humans; Imidazoles; Interleukin-1beta; Intervertebral Disc; Male; Matrix Metalloproteinase 3; Middle Aged; Nitric Oxide; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Signal Transduction; Spinal Diseases; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha

2007